Applied DNA Sciences CEO James Hayward to retire, Judy Murrah to succeed

Applied DNA Sciences (APDN) announced that chairperson and CEO James Hayward is retiring from the company and will step down from the board of directors effective June 18, following a distinguished 20-year term. Furthermore, the board of Applied DNA has appointed Judy Murrah to the roles of chairperson, board director, and CEO in addition to retaining her current position as president. Murrah will lead the executive management team, which comprises Clay Shorrock, chief legal officer and president of LineaRx, the company’s biotherapeutics subsidiary, and Beth Jantzen, CFO.